Testing a new asthma drug in adults
Part of Lungs & breathing clinical trials.
This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must have been diagnosed with asthma and be on a stable treatment plan.
- You must not smoke.
- Your body mass index (BMI) must be between 18.5 and 35.
- You must agree to use birth control if you or your partner could become pregnant.
- You must not have had a severe asthma flare-up, emergency visit, or hospitalization in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
This study tests an investigational drug called PRA-216, first in healthy volunteers to check safety, then in people with mild-to-moderate asthma to see if it helps control symptoms. It's an early-stage trial to find out if the drug is safe and works.
This study tests a slow-release form of DHEA, a natural hormone, to see if it safely improves asthma control in people who already use daily steroid inhalers. It's looking for adults aged 18 to 50 with diagnosed asthma.
This trial tests a new drug called ADO-5030 in people with mild to moderate asthma to see how it affects their airway sensitivity. Participants will have breathing tests using AMP (a substance that can trigger asthma-like symptoms) to measure the drug's effects.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
Hear when a new Safety in Asthma Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.